You can buy or sell ARCA biopharma and other stocks, options, ETFs, and crypto commission-free!
ARCA biopharma, Inc. Common Stock, also called ARCA biopharma, is a biopharmaceutical company, which develops genetically targeted therapies for heart failure and other cardiovascular diseases. Read More The company engages in cardiovascular pathophysiology, molecular genetics and clinical development. Its product candidate, GencaroTM is a pharmacologic beta-blocker and mild vasodilator, which is developed for the treatment of chronic heart failure and other indications. The company was founded by Michael R. Bristow and Christopher David Ozeroff in 1992 and is headquartered in Westminster, CO.
52 Week High
52 Week Low
Health Care Sector Update for 05/09/2019: ABIO, AGEN, ENDP, JNJ, PFE, ABT, MRK, AMGN
Top Health Care Stocks: JNJ: -0.48% PFE: -1.47% ABT: Flat MRK: -1.48% AMGN: -0.67% Health care majors were flat to lower pre-market Thursday. Early movers include: (+) ARCA biopharma ( ABIO ), which was advancing 9% after the company said Q1 net loss per share narrowed to $1.86 from a loss of $3.61 in the year-ago period and topped the CapIQ mean for a loss of $1.98. (+) Agenus ( AGEN ) was trading more than 5% higher after the company reported Q1 earnings of $0.12 per diluted share, up compared wi...
Markets InsiderMay 1
6 Top Gainers In Pharma Sector (ABIO, PRPO, VCYT...)
(RTTNews) - The following are some of today's top gainers in the pharma/biotech sector. 1. ARCA biopharma Inc. (ABIO) ARCA biopharma is a clinical-stage biopharmaceutical company developing genetically-targeted therapies for cardiovascular diseases. The Company's lead product candidate is Gencaro, which is in the development for the treatment of atrial fibrillation in certain patients who also have heart failure (HF). Gencaro is all set to advance into a phase III trial, dubbed PRECISION-AF, in the fourt...
Expected Aug 8, After Hours